Relations Between Atherogenic Index of Plasma-Glucose Metabolism

Sponsor
Erzincan University (Other)
Overall Status
Completed
CT.gov ID
NCT02977598
Collaborator
(none)
448
2
12
224
18.7

Study Details

Study Description

Brief Summary

In this study, the investigators aimed to find out whether there is any association between the atherogenic index of plasma with the glucose metabolism.In this respect, apart from the well-known diabetic risk factors, the investigators purposed to reveal new ones.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Atherogenic index of plasma (AIP) is a relatively new index and a predictor of cardiovascular risk. AIP has been shown to be associated with impaired glucose metabolism. This study aimed to evaluate the relationship between AIP and parameters of glucose metabolism.

    Methods: This observational study involved 448 healthy individuals who were at risk for diabetes. They were sent to hospital for diabetes check. According to the 75 g oral glucose tolerance test participants were categorized into the three groups; non-diabetic, prediabetic, and diabetic based on the criteria of the American Diabetes Association (ADA). The association between the diabetes group, AIP and parameters of glucose metabolism was analyzed.

    The accuracy of registry data compatible with medical records. Statistical analyses were carried out using the Statistical Package for Social Sciences, Windows version 15.0 (SPSS, Chicago, Illinois, USA). Descriptive statistics for each variable were determined. Normality of the data distribution was assessed with the Kolmogorov-Smirnov test. For continuous variables, non-parametric statistics (Mann-Whitney or Kruskal-Wallis), and parametric statistics (t-test, ANOVA analysis) were used as appropriate. Statistically significant differences between the groups were determined by the chi-square test for categorical variables. Associations between the variables were explored using the Pearson correlation and Spearman's rho (for data that was not normally distributed). Linear regression analysis with backward elimination was also performed to define variables associated with AIP.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    448 participants
    Official Title:
    Association Between Atherogenic Index of Plasma, Blood Pressure and Impaired Glucose Metabolism
    Study Start Date :
    Feb 1, 2014
    Actual Primary Completion Date :
    Dec 1, 2014
    Actual Study Completion Date :
    Feb 1, 2015

    Arms and Interventions

    Arm Intervention/Treatment
    non-diabetic

    According to the 75 g oral glucose tolerance test participants were categorized into the three groups; non-diabetic, prediabetic, and diabetic based on the criteria of the American Diabetes Association.

    prediabetic

    According to the 75 g oral glucose tolerance test participants were categorized into the three groups; non-diabetic, prediabetic, and diabetic based on the criteria of the American Diabetes Association.

    diabetic

    According to the 75 g oral glucose tolerance test participants were categorized into the three groups; non-diabetic, prediabetic, and diabetic based on the criteria of the American Diabetes Association.

    Outcome Measures

    Primary Outcome Measures

    1. Atherogenic index of plasma (AIP) values compared with glucose metabolism parameters like HbA1c, Fasting Plasma Glucose and 2-hour plasma glucose levels. [6 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • All the participants were previously healthy, aged between 18 and 80 years, and were at risk for diabetes according to new criteria provided by the American Diabetes Association.
    Exclusion Criteria:
    • Individuals with a history of chronic medical diseases and those who reported current use of any medication were excluded from the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Erzincan Mengucekgazi Research and Training Hospital Erzincan Turkey 00024
    2 Erzincan Mengücekgazi Training and Research Hospital Erzincan Turkey 00024

    Sponsors and Collaborators

    • Erzincan University

    Investigators

    • Principal Investigator: EMIN MURAT AKBAS, Assoc. Prof., ERZINCAN MENGUCEKGAZI TRAINING AND RESEARCH HOSPİTAL DEPARTMENT OF ENDOCRINOLOGY AND METABOLIC DISEASES

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    HILAL ALPCAN, Internal medicine, medical doctor, Erzincan University
    ClinicalTrials.gov Identifier:
    NCT02977598
    Other Study ID Numbers:
    • 44495147/1-202
    First Posted:
    Nov 30, 2016
    Last Update Posted:
    Nov 30, 2016
    Last Verified:
    Nov 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No

    Study Results

    No Results Posted as of Nov 30, 2016